This is an old revision of the document!
SARS-CoV-2 Spike Protein
The SARS-CoV-2 spike glycoprotein stands out as unique.
Potential Pathological Mechanisms of Anti-Spike Antibodies
Blood Clotting
- SARS-CoV-2 spike protein induces abnormal inflammatory blood clots neutralized by fibrin immunotherapy1)
Pathogenic Antibodies
- Pathogenic antibodies induced by spike proteins of COVID-19 and SARS-CoV viruses2)
Genetic Damage
- SARS-CoV-2 Spike Impairs DNA Damage Repair and Inhibits V(D)J Recombination In Vitro3)
Links to Sort
The Functional Consequences of the Novel Ribosomal Pausing Site in SARS-CoV-2 Spike Glycoprotein RNA https://pubmed.ncbi.nlm.nih.gov/34204305/
1)
October 13, 2021 | Jae Kyu Ryu et al | preprint | SARS-CoV-2 spike protein induces abnormal inflammatory blood clots neutralized by fibrin immunotherapy | doi: https://doi.org/10.1101/2021.10.12.464152
2)
June 16, 2021 | Huiru Wang et al | preprint | Pathogenic antibodies induced by spike proteins of COVID-19 and SARS-CoV viruses | DOI: https://doi.org/10.21203/rs.3.rs-612103/v2
3)
October 13, 2021 | Hui Jiang and Ya-Fang Mei | SARS-CoV-2 Spike Impairs DNA Damage Repair and Inhibits V(D)J Recombination In Vitro | DOI: 10.3390/v13102056